Literature DB >> 15489639

Innate immune response in Th1- and Th2-dominant mouse strains.

Hiroyuki Watanabe1, Kousuke Numata, Takaaki Ito, Katsumasa Takagi, Akihiro Matsukawa.   

Abstract

C57BL/6 and BALB/c mice are prototypical Th1- and Th2-type mouse strains, respectively. In the present study, we attempted to characterize the innate immune response of macrophages from these mouse strains. Macrophages from C57BL/6 mice produced higher levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-12 than those from BALB/c mice after stimulation with macrophage-activating lipopeptide-2 (MALP-2, a synthetic TLR-2 ligand) or lipopolysaccharide (LPS, a TLR-4 ligand). The augmented IL-12 production by C57BL/6 macrophages increased interferon-gamma and, in contrast, decreased IL-13 production by CD4+ T cells. On stimulation with MALP-2 or LPS, C57BL/6 macrophages produced lysosomal enzyme and nitric oxide, effector molecules for bacterial killing, whereas BALB/c macrophages did not. Bactericidal activity of BALB/c macrophages was impaired relative to C57BL/6 macrophages when cells were infected with live bacteria in vitro. In a murine model of septic peritonitis induced by cecal ligation and puncture (CLP), BALB/c mice failed to facilitate bacterial clearance relative to C57BL/6 mice despite an augmented peritoneal leukocyte infiltration that was associated with increased peritoneal levels of cytokines/chemokines. BALB/c mice exhibited increased plasma and hepatic levels of cytokines/chemokines, resulting in an exaggerated systemic inflammation as determined by acute-phase proteins. Finally, BALB/c mice were vulnerable to CLP-induced lethality relative to C57BL/6 mice. Altogether, innate immune response of macrophages is different between these mouse strains, which may affect the development of Th1 and Th2 adaptive immunity in these strains. Reduced systemic inflammatory response in C57BL/6 mice that may result from an eminent local response appears to be beneficial during sepsis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489639     DOI: 10.1097/01.shk.0000142249.08135.e9

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  187 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

Review 2.  Strain-Related Differences in the Immune Response: Relevance to Human Stroke.

Authors:  Kyra J Becker
Journal:  Transl Stroke Res       Date:  2016-02-10       Impact factor: 6.829

Review 3.  Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Authors:  L Morici; A G Torres; R W Titball
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

4.  Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin.

Authors:  A Cougnoux; S Clifford; A Salman; S-L Ng; J Bertin; F D Porter
Journal:  Mol Genet Metab       Date:  2018-10-30       Impact factor: 4.797

5.  TLR2 and NODs1 and 2 cooperate in inflammatory responses associated with renal ischemia reperfusion injury.

Authors:  Sashi G Kasimsetty; Alana Hawkes; Kayvan Barekatain; Elizabeth Soo; Alexander K Welch; Dianne B McKay
Journal:  Transpl Immunol       Date:  2019-11-22       Impact factor: 1.708

Review 6.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

7.  Concerns over interspecies transcriptional comparisons in mice and humans after trauma.

Authors:  Andrew R Osterburg; Philip Hexley; Dorothy M Supp; Chad T Robinson; Greg Noel; Cora Ogle; Steven T Boyce; Bruce J Aronow; George F Babcock
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

Review 8.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

9.  Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations.

Authors:  Jonathan A Hensel; Vinayak Khattar; Reading Ashton; Selvarangan Ponnazhagan
Journal:  Lab Invest       Date:  2018-10-23       Impact factor: 5.662

10.  BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.

Authors:  Anna C Belkina; Barbara S Nikolajczyk; Gerald V Denis
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.